Valuation: Medpace Holdings, Inc.

Market Cap 16.33B 14.17B 13.27B 12.14B 22.91B 1,555B 23.21B 155B 60.92B 777B 61.31B 59.97B 2,587B P/E 2026 *
33.3x
P/E 2027 * 30.5x
Enterprise Value 15.53B 13.47B 12.62B 11.54B 21.79B 1,479B 22.07B 148B 57.93B 739B 58.3B 57.03B 2,460B EV / Sales 2026 *
5.44x
EV / Sales 2027 * 4.98x
Free-Float
79.98%
Yield 2026 *
-
Yield 2027 * -
1 day-0.47%
1 week+1.16%
Current month+1.37%
1 month+3.53%
3 months+37.07%
6 months+7.93%
Current year+4.16%
1 week 563.45
Extreme 563.45
590.4
1 month 514.47
Extreme 514.47
677.9
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap.
28/07/26 Sell

Chief Operating Officer

-7,500 0.0263%
28/07/26 Sell

Chief Executive Officer

-3,510 0.0123%
30/06/26 Fiscal year

Director

66 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.47%+1.16%+35.93%+126.09% 16.33B
+2.05%+2.60%+4.91%+17.67% 48.7B
+0.26%+2.93%+439.43%+533.80% 42.05B
-1.53%-2.25%+30.95%+7.15% 38.26B
+0.69%+2.40%+10.48%+63.05% 37.5B
+2.47%+2.63%+14.71%+48.37% 31.44B
+2.31%-0.49% - - 16.47B
+1.29%+3.84%+7.73%+20.54% 13.98B
-1.43%-2.63%+3.70%-36.38% 12.43B
+1.84%+13.17%+76.62%+28.33% 12.68B
Average +0.76%+2.00%+69.38%+89.84% 26.98B
Weighted average by Cap. +0.80%+1.51%+88.69%+117.30%

Financials

2026 *2027 *
Net sales 2.85B 2.47B 2.32B 2.12B 4B 272B 4.05B 27.11B 10.64B 136B 10.71B 10.47B 452B 3.03B 2.63B 2.46B 2.25B 4.25B 288B 4.3B 28.78B 11.29B 144B 11.36B 11.12B 480B
Net income 503M 436M 408M 374M 705M 47.87B 714M 4.78B 1.87B 23.92B 1.89B 1.85B 79.61B 547M 474M 444M 406M 767M 52.07B 777M 5.2B 2.04B 26.01B 2.05B 2.01B 86.59B
Net Debt -802M -696M -652M -596M -1.13B -76.42B -1.14B -7.63B -2.99B -38.18B -3.01B -2.95B -127B -1.25B -1.09B -1.02B -931M -1.76B -119B -1.78B -11.9B -4.67B -59.6B -4.7B -4.6B -198B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
06/08/26 $585.01 -0.47% 148,658
05/08/26 $587.75 +2.20% 246,169
04/08/26 $575.08 +0.31% 227,919
03/08/26 $573.29 -0.66% 249,533
31/07/26 $577.11 -0.21% 261,431
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
585.01USD
Average target price
581.83USD
Spread / Average Target
-0.54%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock